Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Association of preoperative EpCAM Circulating Tumor Cells and peripheral Treg cell levels with early recurrence of hepatocellular carcinoma following radical hepatic resection

Fig. 3

The Prognostic significance of EpCAM mRNA+ CTC and Treg/CD4+ ratio in HCC patients. a. Kaplan–Meier analysis of HCC patients receiving curative resection treatment according to relative preoperative EpCAM expression <2.22 or ≥2.22 (2−ΔΔC q algorithm transformation). b. Kaplan–Meier analysis of patients with HCC undergoing curative resection according to preoperative Treg/CD4+ <5.07 % or ≥5.07 %. c. Prognostic significance of combination of EpCAM mRNA+ CTC and Treg/CD4+ load with respect to time to recurrence in patients with high EpCAM mRNA+ CTC (≥2.22) and high Treg/CD4+(≥5.07 %), high EpCAM mRNA+ CTC(<2.22) and low Treg/CD4+(<5.07 %), low/no EpCAM mRNA+ CTC (<2.22) and high Treg/CD4+(≥5.07 %), and low/no EpCAM mRNA+ CTC (<2.22) and low Treg/CD4+(<5.07 %)

Back to article page